Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 672

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 672
---
 of the Mergers and accordingly a $3,562,115 adjustment to reflect the increase
in cash for TuHURA upon the receipt of cash for these exercises is presented (consisting of the $3,057,904 notes to be realized before the Closing plus the $504,211 already received). Additionally, as described in Note 1 in the notes to the
unaudited pro forma condensed combined financial information, the Penny Warrants are effectively pre-funded, resulting in nominal additional cash for TuHURA upon exercise, and the net zero impact to Additional
paid-in capital is already reflected within TuHURA’s historical financial statements as of December 31, 2024. Accordingly, as the Penny Warrants are assumed to be exercised to give pro forma effect
to the Kintara Mergers, the Mergers and all related transactions, the net amount of the cash received for the TuHURA warrants exercised of $3,562,115, and shares of TuHURA Common Stock issued of 1,653

448

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION at par value after the exercise of the TuHURA warrants and Penny Warrants, comprised of $3,560,462 to Additional paid-incapital is reflected as a pro forma adjustment in the unaudited pro forma condensed combined balance sheet as of December 31, 2024. Transaction Accounting Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet The transaction accounting adjustments included in the unaudited pro forma condensed combined balance sheet as of December 31, 2024 are as follows: ERepresents adjustments for the estimated preliminary purchase price allocation for the Mergers between TuHURA Biosciences, Inc. and Kineta; including the resulting elimination of Kineta’s historical equity, in addition to the issuances of further Kineta equity subsequent to December 31, 2024 and up until the Effective Time, as a result of the acquisition by TuHURA. Any adjustments presented on the unaudited pro forma condensed combined balance sheet as of December 31, 2024, which reference this Pro Forma Adjustment Ewhile not being explicitly depicted in the table below, are the result of the net presentation of the estimated preliminary purchase price allocation adjustments in the unaudited pro forma condensed combined balance sheet after accounting for the elimination of Kineta’s historical equity, the elimination of Kineta’s additional equity issuances expected in connection with